Munich, Bavaria, Germany
computational pathology biomarker research and development in oncology, product strategy and management, investor relations, business strategy, intellectual property management, inventor of 20+ patents, artificial intelligence and deep learning, software development C++, Java and Python, acquisition and management of public funded research projects
Supporting and shaping the AZ Oncology drug and biomarker pipeline with AI-based computational pathology. Contributing to the AZ Oncology R&D Data Science and AI strategy and implementation.
Definiens GmbH is a part of the AstraZeneca Oncology Translational Science organization.
Responsible for technology strategy, scientific research team, and global intellectual property strategy and management
Responsible for all Definiens products, and the Definiens patent and trademark portfolio
Heading the Definiens research team, responsible for BMBF and BFS public funded research projects
Responsible for all Intellectual Properties (IP) and the global IP strategy. Project lead in eCognition related research activities.
Proteomweaver is the leading software to analyse automatically 2D gel electrophoresis images. Responsible for Product Development (C++), Marketing and Support. Successful asset sale in 2005 to Bio-Rad Laboratories.
Responsible for all Definiens activities in Systems Biology with focus on extracting protein networks from text and integrating proteomic data from 2D gel electrophoresis and cell-based assays.
Project Manager eSight, an object-oriented simulation toolkit, software design and implementation (Java), Head of the modelling group.for dynamic systems in economics and ecology.